Kytopen is speeding up both discovery and delivery of engineered cell therapies with its transformative Flowfect platforms.
KSQ Therapeutics uses technology created at MIT to study the role of every human gene in disease biology.
Caroline Uhler blends machine learning, statistics, and biology to understand how our bodies respond to illness.
Encapsulating modified bacteria in tough hydrogel spheres prevents them from spreading genes to other microbes.
Varying levels of a DNA repair enzyme can lead to very different outcomes after exposure to NDMA.
The gene variant disrupts lipid metabolism, but in cell experiments the effects were reversed by choline supplements.
Kano Therapeutics was one of eight finalists to pitch at the virtual competition.
A new computational approach for analyzing complex datasets shows that as disease progresses, neurons and astrocytes lose the ability to maintain homeostasis.